American Association for Cancer Research, Cancer Immunology Research, 1(10), p. 4-4, 2022
DOI: 10.1158/2326-6066.cir-21-0977
Full text: Unavailable
Abstract Macrophages are in the spotlight of cancer immunotherapy research because they exert a wide spectrum of protumorigenic functions. In this issue, Pfirschke and colleagues report that macrophage targeting pulls the strings of the tumor microenvironment, ultimately leading to a coordinated antitumorigenic immune reaction in a lung carcinoma mouse model. See related article by Pfirschke et al., p. 40. (4).